Hjem › Depression › Arkansas
Depression kliniske forsøg i Arkansas
10 studier for Depression søger deltagere på steder i Arkansas.
Byer i Arkansas
Officiel studietekst (engelsk)
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Pillar Clinical Research, Bentonville
- SanRo Clinical Research Group, Bryant
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 8. sep. 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Little Rock
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bentonville
- Draig Clinical Site, Little Rock
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 26. aug. 2026 · NCT07300969NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Bryant
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT06911112E-Mindfulness Approaches for Living After Breast Cancer
- Mercy Hospital Fort Smith, Fort Smith
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
- University of Arkansas for Medical Sciences, Little Rock
RekruttererFase 3
Alder 18 til 50 · Alle køn · Opdateret 4. aug. 2026 · NCT06748222A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Woodland International Research Group, Little Rock
- Woodland Research Northwest, Rogers
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 3. aug. 2026 · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT06966401A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
- Woodland Research Northwest, Rogers
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 11. maj 2026 · NCT06524830Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons
- University of Arkansas for Medical Sciences, Little Rock
- Northeast Arkansas Community Corrections Center (NEACC), Osceola
- Southwest Arkansas Community Correction Center, Texarkana
- og 1 flere
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 21. jan. 2026 · NCT06923423Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Little Rock
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 29. okt. 2025 · NCT06786624Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.